Document is current

Article History

Received: 6 February 2018

Accepted: 30 July 2018

First Online: 20 August 2018

Ethics approval and consent to participate

: Written informed consent was obtained from the patient as part of a University of California, Los Angeles (UCLA) Institutional Review Board (IRB#10–001857) approved protocol. Written informed consent was obtained from the patient for publication of the study. All mice investigations were done with an AntiCancer, Inc. Institutional Animal Care and Use Committee (IACUC)-protocol mainly approved for this study and in correspondence with the principals and procedures outlined in the National Institute of Health (NIH) Guide for the Care and Use of Animals under Assurance Number A3873–1.

: Written informed consent was obtained from the patient for publication of the study.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.